Yutang Li
Key Laboratory Of Medical Molecular Virology
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 12, 2023
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
Journal: Emerging microbes & infections
Published: July 26, 2021
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
Journal: Signal transduction and targeted therapy
Published: June 11, 2021
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.
Journal: Signal transduction and targeted therapy
Published: April 10, 2021
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
Journal: Signal transduction and targeted therapy
Published: December 29, 2020
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Journal: Nature communications
Published: September 16, 2020
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2.
Journal: Science bulletin
Published: September 04, 2020
Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China.
Journal: Infection and drug resistance
Published: October 17, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026